SEC Filing Summary: Intrexon Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Intrexon Corporation on January 10, 2018. The report discloses a presentation scheduled for delivery at the 2018 J.P. Morgan Healthcare Conference on the same date. The presentation slides are included as Exhibit 99.1.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of the conference presentation and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is limited to the disclosure of forward-looking information contained in the conference presentation.
Guidance, Outlook, and Risks
Management commentary and outlook are contained within the attached presentation (Exhibit 99.1), which is incorporated by reference. The filing explicitly states that the information in Item 7.01 and the exhibit will not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor will they be incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of the J.P. Morgan Healthcare Conference presentation (Exhibit 99.1) for specific strategic updates or guidance.
- Note that the presentation materials are not legally "filed" with the SEC and carry different liability standards than formal financial reports.
- Confirm the registrant's identity as Intrexon Corporation, noting the discrepancy with the request metadata which listed "PRECIGEN, INC."
- Review subsequent filings for any financial data referenced in the presentation.